Bristol Myers Squibb reached a $239 million settlement of claims that former Celgene shareholders were defrauded about prospects for the psoriasis drug Otezla, and multiple sclerosis treatment now ...
A federal judge has approved a $6.75 million settlement in a class-action lawsuit over violence against inmates at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback